1WA
180 Wealth Advisors’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $357K | Buy |
7,345
+996
| +16% | +$48.4K | 0.05% | 301 |
|
|
2025
Q1 | $216K | Buy |
6,349
+1,182
| +23% | +$40.2K | 0.03% | 362 |
|
|
2024
Q4 | $203K | Buy |
5,167
+803
| +18% | +$31.6K | 0.03% | 391 |
|
|
2024
Q3 | $205K | Buy |
4,364
+663
| +18% | +$31.1K | 0.03% | 408 |
|
|
2024
Q2 | $210K | Buy |
+3,701
| New | +$210K | 0.03% | 395 |
|
|
2022
Q4 | – | Sell |
-3,073
| Closed | -$201K | – | 373 |
|
|
2022
Q3 | $201K | Buy |
+3,073
| New | +$201K | 0.06% | 320 |
|